Budget 2026: Healthcare ko R&D boost, GST relief, aur saste meds chahiye

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorRiya Kapoor|Published at:
Budget 2026: Healthcare ko R&D boost, GST relief, aur saste meds chahiye
Overview

India ka healthcare industry Budget 2026 mein substantial allocations ke liye lobby kar raha hai, R&D funding, startup support, aur GST reforms ko prioritize karte hue. Dr. Reddy's aur Poly Medicure jaise key players domestic manufacturing ko badhane, exports ko boost karne, aur tariffs jaise global challenges ko manage karne ke liye policies push kar rahe hain. Innovation aur cost-effective treatments par focus paramount hai.

R&D aur Innovation Push

Indian pharma sector growth ke liye ready hai, $120-130 billion by 2030 ka target hai. Lekin, trade tariffs aur supply chain issues jaise global challenges ke liye mazboot domestic R&D framework chahiye. Industry leaders ka kehna hai ki advanced research ko high-value therapies aur complex generics mein transform karne ke liye structured funding zaroori hai, taaki innovation-led model ban sake.

GST Reforms for Manufacturing

Manufacturers, especially medical devices segment mein, GST inversion se pareshan hain. Poly Medicure ka kehna hai ki finished devices par 5% tax, inputs par 18% duty ke muqable mein bahot kam hai, jis se input tax credit jama ho raha hai aur working capital par pressure aa raha hai. Job-work GST rates ko pharma sector ke 5% ke saath align karna aur refund formulas mein input services aur capital goods ko shamil karna critical demands hain.

Child Welfare aur Preventive Health

Child welfare spending par chinta hai, GDP share mein girawat dikhi hai, halanki Union Budget mein allocation thoda badha hai. Paediatrics mein postgraduate training positions badhana aur essential child check-ups ke liye tax deductions increase karna key proposals hain. Aur, non-communicable diseases (NCDs) se 2030 tak 75% mortality hone ka andaaza hai, isiliye preventive healthcare ki taraf focus badhana, diagnostics ko mazboot karna, aur NCD resilience fund banana zaroori mana ja raha hai.

Digital Health aur AI Integration

Healthcare mein Artificial Intelligence (AI) ka integration early diagnosis aur treatment ke liye crucial mana ja raha hai. Philips jaise companies AI-driven innovations ko prioritize karne wale incentives ke liye urge kar rahe hain. Sustainable MedTech manufacturing ecosystem develop karna, PLI schemes se supported, bhi ek priority hai taaki India ek global export hub ban sake.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.